GSK3B and familial pancreatic carcinoma: GSK3β reportedly stimulates the development of certain tumors, including those in pancreatic cancer, colorectal cancer and myeloma cancer, while inhibiting the development of other tumors, including those in lung, esophageal, and breast cancer (164–166).